Friday 28th May 2021 |
Text too small? |
Listed primary healthcare provider Green Cross Health, the Group behind Unichem and Life Pharmacy, The Doctors and Access Community Health, reported Net Profit After Tax Attributable to Shareholders of $16.8 million was in line with the underlying prior year result and includes growth in the Medical and Community Health divisions, offsetting retail softness in the Pharmacy division.
Future Focus and Dividend
Whilst the Board accepts there is still some uncertainty ahead, it is pleased with how the Company has weathered the COVID-19 uncertainties, producing both a solid profit performance and performing an important primary healthcare role for the community in the most trying of times.
The Company continues to engage with District Health Boards and the Ministry of Health, highlighting our ability and willingness to play an increased role in the COVID-19 vaccine programme as it extends to all New Zealanders.
Green Cross Health is committed to meeting patient and customer expectations, providing all New Zealanders accessible, quality primary healthcare. As part of this commitment, we are advocating for the removal of the prescription co-payment Government tax and are expectant that the implementation of the New Zealand Health & Disability System Reforms will see the improved accessibility and affordability of primary healthcare for New Zealand communities.
The Board has decided not to declare a final FY21 dividend in order to preserve cash to assist the Company with accelerating its acquisition activities.
Please see the links below for details
GXH Media Release 31 March 2021
GXH Financial Statements 31 March 2021
GXH Annual Results Presentation 31 March 2021
GXH NZX appendix 1 31 March 2021
Source: Green Cross Health Limited
No comments yet
GTK - Half-Year Results Announcement Date
Government ends war on farming
Sky and BBC Studios renew expanded, multi-year agreement
AOF - Q1 Improved Trading Performance & FY24 Guidance Maintained
Devon Funds Morning Note - 23 April 2024
April 23rd Morning Report
RYM - Group CEO Update
BGI - Director Michael Chai
RAD - Final Dividend and Strong FY24 Operating Performance
RYM - Group CEO Update